End-of-life care in heart failure

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The clinical syndrome of heart failure is increasing in prevalence, as is the number of elderly persons with heart failure. Increasing frailty and progression of heart failure in large numbers of patients means clinicians are increasingly challenged to provide end-of-life care for heart failure patients. End-of-life care has been little studied, but management can be understood from early clinical trials of advanced heart failure. Evidence-based heart failure medications, including angiotensin-converting enzyme inhibitors and β blockers, improve symptoms in patients with advanced heart failure and depressed ejection fraction and should usually be continued in end-stage disease. Patients also should have ongoing meticulous management of fluid status to maximize quality of life. End-of-life care should be planned with the patient and family and should incorporate comprehensive symptom management, bereavement support, and spiritual support. Ongoing communication with patients and families about prognosis can ease the planning of care when the end of life nears.

Original languageEnglish (US)
Pages (from-to)184-191
Number of pages8
JournalCurrent Cardiology Reports
Volume11
Issue number3
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Terminal Care
Heart Failure
Bereavement
Angiotensin-Converting Enzyme Inhibitors
Communication
Quality of Life
Clinical Trials

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

End-of-life care in heart failure. / Goodlin, Sarah.

In: Current Cardiology Reports, Vol. 11, No. 3, 2009, p. 184-191.

Research output: Contribution to journalArticle

@article{32b140de20a540b6b5f904b0662bf32f,
title = "End-of-life care in heart failure",
abstract = "The clinical syndrome of heart failure is increasing in prevalence, as is the number of elderly persons with heart failure. Increasing frailty and progression of heart failure in large numbers of patients means clinicians are increasingly challenged to provide end-of-life care for heart failure patients. End-of-life care has been little studied, but management can be understood from early clinical trials of advanced heart failure. Evidence-based heart failure medications, including angiotensin-converting enzyme inhibitors and β blockers, improve symptoms in patients with advanced heart failure and depressed ejection fraction and should usually be continued in end-stage disease. Patients also should have ongoing meticulous management of fluid status to maximize quality of life. End-of-life care should be planned with the patient and family and should incorporate comprehensive symptom management, bereavement support, and spiritual support. Ongoing communication with patients and families about prognosis can ease the planning of care when the end of life nears.",
author = "Sarah Goodlin",
year = "2009",
doi = "10.1007/s11886-009-0027-7",
language = "English (US)",
volume = "11",
pages = "184--191",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - End-of-life care in heart failure

AU - Goodlin, Sarah

PY - 2009

Y1 - 2009

N2 - The clinical syndrome of heart failure is increasing in prevalence, as is the number of elderly persons with heart failure. Increasing frailty and progression of heart failure in large numbers of patients means clinicians are increasingly challenged to provide end-of-life care for heart failure patients. End-of-life care has been little studied, but management can be understood from early clinical trials of advanced heart failure. Evidence-based heart failure medications, including angiotensin-converting enzyme inhibitors and β blockers, improve symptoms in patients with advanced heart failure and depressed ejection fraction and should usually be continued in end-stage disease. Patients also should have ongoing meticulous management of fluid status to maximize quality of life. End-of-life care should be planned with the patient and family and should incorporate comprehensive symptom management, bereavement support, and spiritual support. Ongoing communication with patients and families about prognosis can ease the planning of care when the end of life nears.

AB - The clinical syndrome of heart failure is increasing in prevalence, as is the number of elderly persons with heart failure. Increasing frailty and progression of heart failure in large numbers of patients means clinicians are increasingly challenged to provide end-of-life care for heart failure patients. End-of-life care has been little studied, but management can be understood from early clinical trials of advanced heart failure. Evidence-based heart failure medications, including angiotensin-converting enzyme inhibitors and β blockers, improve symptoms in patients with advanced heart failure and depressed ejection fraction and should usually be continued in end-stage disease. Patients also should have ongoing meticulous management of fluid status to maximize quality of life. End-of-life care should be planned with the patient and family and should incorporate comprehensive symptom management, bereavement support, and spiritual support. Ongoing communication with patients and families about prognosis can ease the planning of care when the end of life nears.

UR - http://www.scopus.com/inward/record.url?scp=65549086521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549086521&partnerID=8YFLogxK

U2 - 10.1007/s11886-009-0027-7

DO - 10.1007/s11886-009-0027-7

M3 - Article

VL - 11

SP - 184

EP - 191

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 3

ER -